Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PARNAX LAB LTD. - 506128 - Notice Of 40Th Annual General Meeting To Be Held On 28Th September, 2022

 Dear Sir / Madam, We wish to inform you that the 40th Annual General Meeting ('AGM') of the members of the Company will be held on Wednesday, 28th September, 2022 at 03.00 P.M. (IST) through Video Conferencing ('VC') / Other Audio-Visual Means('OVAM'), which will be deemed to be held at the registered office of the Company to transact the business as set out in Notice convening the said AGM in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities Exchange Board of India. Please find enclosed Notice convening 40th Annual General Meeting and Annual Report of the Company for the Financial Year 2021-22, which is also being sent through electronic mode to those Shareholders of the Company whose email addresses are registered with the Company/ Depositories/Registrar and Transfer Agent, in accordance with aforesaid Circulars for your records. Kindly take the above information for your record.
06-09-2022
Bigul

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement regarding the publication of Notice to shareholders for registration/ updation of their Email- Id"s.
03-09-2022
Bigul

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Advertisement regarding the publication of Notice to shareholders for registration/ updation of their Email- Id"s.
03-09-2022
Bigul

PARNAX LAB LTD. - 506128 - Corporate Action- Fixes Book Closure For Annual General Meeting

 This is to inform you that the Register of Members and Share transfer books of the company will remain closed from Thursday, 22nd September, 2022 to Wednesday, 28th September, 2022 (both days inclusive) for the purpose of the 40th Annual General Meeting (AGM) of the Company to be held on 28th September, 2022.
01-09-2022
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Outcome Of Board Meeting

 Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, 1st September, 2022 at its Registered Office, the Board inter alia has transacted the following business: 1. To approve the Notice of the Annual General Meeting, along with the Director Report of the Company for the Financial Year ended 31st March, 2022; 2. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The Meeting commenced at 6.30 p.m. and concluded at 7.30 p.m.
01-09-2022
Bigul

PARNAX LAB LTD. - 506128 - Results-Un-Audited Financial Results For The Quarter Ended June 30, 2022.

 Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial Results of the Company for the quarter and three months ended 30th June, 2022, along with Limited Review Report thereon, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. The aforesaid information and Financial Results are being made available on the Company''s website at www.naxparlab.com Kindly take on your record and acknowledge receipt of the same. Thanking You,
10-08-2022
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Outcome Of Board Meeting

 Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Wednesday, 10th August, 2022 at its Registered Office, the Board inter alia has transacted the following business: 1. Considered and Approved the Standalone & Consolidated Un-Audited Financial Results of the Company for the quarter and three months ended 30th June, 2022, along with Limited Review Report thereon. 2. Fixed the date of the 40th Annual General Meeting to be held on 28th September 2022 through Video Conferencing (VC)/ other Audio-visual means (OVAM). The Meeting commenced at 5.00 p.m. and concluded at 6.15 p.m.
10-08-2022
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2022.

 PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 ,inter alia, to consider and approve Dear Sir, This is to inform you that, the meeting of the Board of Directors of the Company PARNAX LAB LIMITED will be held on Wednesday, 10th August, 2022 at the registered office of the Company to transact the following business. 1. To approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and three months ended 30th June, 2022, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. To decide the date of the Annual General Meeting of the Company for the Financial Year ended 31st March, 2022; 3. Any other business with the permission of the chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. The approved results will be sent to you after the conclusion of the Board meeting. Kindly acknowledge the receipt of the same and Oblige
02-08-2022
Bigul

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir, In reference to the above-captioned regulation, we have received confirmation from our Registrar & Transfer Agents Link Intime India Pvt. Ltd., that since there were no dematerialization requests during the quarter ended 30th June 2022, therefore the Confirmation certificate as per Regulation 74 (5) is attached herewith. This is for your information and records.
19-07-2022
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended June 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Preet Vijay KukrejaDesignation :- Company Secretary and Compliance Officer
15-07-2022
Next Page
Close

Let's Open Free Demat Account